On Monday, CMC Vellore approached the drug regulator’s office to share preliminary results of the study on the feasibility of mixing Covishield and Covaxin, Winsley Rose, principal investigator of the study, told ET on Tuesday. “After the Subject Expert Committee (SEC) reviews the data of the study, the data will be shared with NTAGI,” said the official cited above.from Industry-Economic Times
Read The Rest:economictimes...
